Company Overview of Sucampo Pharmaceuticals, Inc.
Peter S. Greenleaf
Chairman and Chief Executive Officer, Sucampo Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 4 Board Members in 4 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2015
805 King Farm BoulevardPhone: 301-961-3400
Rockville, Maryland 20850
Board Members Memberships
Chairman and Chief Executive Officer
Director, Member of Compensation Committee and Member of Audit Committee
Saint Joseph's University
Western Connecticut State University
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science Committee|
Progenics Pharmaceuticals, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|A. J. Kazimi MBA||Founder, Chairman, Chief Executive Officer and President|
Cumberland Pharmaceuticals, Inc.
|John Anthony Sedor||Chairman of the Board, Interim Chief Executive Officer and Member of Nominating Committee|
Pernix Therapeutics Holdings, Inc.
|Allan Oberman||Chief Executive Officer and Director|
Sagent Pharmaceuticals, Inc.
|$244.7K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.